ES2053585T3 - Utilizacion de interferon-alfa bovino en la obtencion de un medicamento para el tratamiento profilactico de las vacas contra las enfermedades comprendidas bajo el termino generico de complejo de gripe bovina. - Google Patents

Utilizacion de interferon-alfa bovino en la obtencion de un medicamento para el tratamiento profilactico de las vacas contra las enfermedades comprendidas bajo el termino generico de complejo de gripe bovina.

Info

Publication number
ES2053585T3
ES2053585T3 ES87810723T ES87810723T ES2053585T3 ES 2053585 T3 ES2053585 T3 ES 2053585T3 ES 87810723 T ES87810723 T ES 87810723T ES 87810723 T ES87810723 T ES 87810723T ES 2053585 T3 ES2053585 T3 ES 2053585T3
Authority
ES
Spain
Prior art keywords
interferon
bovine
bovino
alfa
obtaining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87810723T
Other languages
English (en)
Inventor
Kevin Anderson
Lorne Babiuk
Joseph Stephen Mccracken
Helle Bielefeldt Ohmann
John Philip
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Application granted granted Critical
Publication of ES2053585T3 publication Critical patent/ES2053585T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

EL OBJETO DE LA PRESENTE INVENCION SE REFIERE AL AMBITO DE LA SALUD ANIMAL FIJANDO COMO OBJETIVO PRINCIPAL LAS MEDIDAS PARA COMBATIR LA ENFERMEDAD RESPIRATORIA COMPLEJA DE LOS VACUNOS (GRIPE BOVINA COMPLEJA). DE ACUERDO CON LA INVENCION ESTE PROBLEMA HA PODIDO RESOLVERSE ADMINISTRANDO SISTEMICAMENTE A LOS VACUNOS JOVENES UNA CANTIDAD PROFILACTICAMENTE EFECTIVA DE INTERFERON VACUNO, REALIZANDOSE ESTOANTES DE QUE SE HAYA EFECTUADO UNA INYECCION DE UN VIRUS O MICROORGANISMO INFECCIOSO CAUSANTE DE LA ENFERMEDAD, O DE QUE SE HAYA EXTENDIDO.
ES87810723T 1986-12-12 1987-12-07 Utilizacion de interferon-alfa bovino en la obtencion de un medicamento para el tratamiento profilactico de las vacas contra las enfermedades comprendidas bajo el termino generico de complejo de gripe bovina. Expired - Lifetime ES2053585T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94145386A 1986-12-12 1986-12-12
US11784087A 1987-11-13 1987-11-13

Publications (1)

Publication Number Publication Date
ES2053585T3 true ES2053585T3 (es) 1994-08-01

Family

ID=26815704

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87810723T Expired - Lifetime ES2053585T3 (es) 1986-12-12 1987-12-07 Utilizacion de interferon-alfa bovino en la obtencion de un medicamento para el tratamiento profilactico de las vacas contra las enfermedades comprendidas bajo el termino generico de complejo de gripe bovina.

Country Status (10)

Country Link
EP (1) EP0271447B1 (es)
JP (1) JPH0725694B2 (es)
AU (1) AU609435B2 (es)
CA (1) CA1329122C (es)
DE (1) DE3784650D1 (es)
ES (1) ES2053585T3 (es)
GR (1) GR3007798T3 (es)
IE (1) IE59917B1 (es)
IL (1) IL84777A (es)
NZ (1) NZ222875A (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4944941A (en) * 1987-08-07 1990-07-31 Genentech, Inc. Methods and compositions for the treatment of lung conditions
US5049378A (en) * 1989-04-24 1991-09-17 Ciba-Geigy Canada Ltd. Prevention and treatment of porcine haemophilus pneumonia (PHP)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE54592B1 (en) * 1982-03-08 1989-12-06 Genentech Inc Anumal interferons, processes involved in their production, compositions containing them, dna sequences coding therefor and espression vehicles containing such sequences and cells transformed thereby
IL71555A (en) * 1984-04-15 1992-06-21 State Of Israel Israel Inst Fo Bovine interferon
AU588332B2 (en) * 1986-07-04 1989-09-14 Tachi-S Co., Ltd. Seat suspension device

Also Published As

Publication number Publication date
CA1329122C (en) 1994-05-03
IL84777A0 (en) 1988-05-31
JPS63239235A (ja) 1988-10-05
IE59917B1 (en) 1994-04-20
JPH0725694B2 (ja) 1995-03-22
AU609435B2 (en) 1991-05-02
GR3007798T3 (es) 1993-08-31
EP0271447A2 (de) 1988-06-15
EP0271447A3 (en) 1989-03-08
AU8246687A (en) 1988-06-16
NZ222875A (en) 1990-10-26
EP0271447B1 (de) 1993-03-10
IL84777A (en) 1992-12-01
IE873366L (en) 1988-06-12
DE3784650D1 (de) 1993-04-15

Similar Documents

Publication Publication Date Title
GR3025502T3 (en) Drugs, their manufacture, and their use as painkillers and/or to treat inflammations in humans and animals.
ES475854A1 (es) Un procedimiento para preparar derivados de glicosido de pleuromutilina
DK184186D0 (da) Terapeutisk praeparat til behandling af virussygdomme
ES2155473T3 (es) Composicion veterinaria que contiene un inhibidor de las bombas de protones.
ATE258065T1 (de) Behandlung von autoimmun-erkrankungen durch orale verabreichung von autoantigenen
ES2187575T3 (es) Hexapeptidos ciclicos dotados de actividad antibiotica.
KR930702026A (ko) 자기항원의 경구 투여에 의한 자기면역 질병의 치료
ATE135365T1 (de) Antivirale verbindungen
CO5611162A2 (es) Metodos para prevenir enfermedades reproductivas en el ganado vacuno
SE8703066D0 (sv) Antiseptic composition containing ethyl alcohol and monolaurin
DE69025271D1 (de) Pharmazeutische Zubereitungen mit verzögerter Freisetzung zur Behandlung periodontaler Erkrankungen
AR017877A1 (es) Metodo para el tratamiento profilactico de la mastitis y su uso de al menos un tipo de xantofila para preparar medicamentos de aplicacion en dicho metodo
AR041891A1 (es) Empleo de resveratrol para la preparacion de un medicamento util para el tratamiento de infecciones causadas por el virus de la influenza
DK0904780T3 (da) Anvendelse af farmaceutiske præparater omfattende thymol og/eller carvacrol mod histomoniasis
ES2053585T3 (es) Utilizacion de interferon-alfa bovino en la obtencion de un medicamento para el tratamiento profilactico de las vacas contra las enfermedades comprendidas bajo el termino generico de complejo de gripe bovina.
BR0116653A (pt) Medicamento contendo uma poliamina como substância ativa
CN101869601B (zh) 一种外用兽药
MX2022011539A (es) Metodo de produccion de una composicion de suero para la prevencion o el tratamiento de enfermedades infecciosas relacionadas con las mucosas en mamiferos jovenes, composicion de suero producida de este modo y uso de la misma.
ES2052579T3 (es) Empleo de interferon alfa humano recombinante para la fabricacion de un medicamento para tratar el virus del sida.
DE69925312D1 (de) Bupropion zur behandlung von viralen erkrankungen
EA199800770A1 (ru) Лекарственный препарат для терапевтического лечения вирусного гепатита
ES2059615T3 (es) Empleo del derivado de tiazol tiprotimoda para la preparacion de un agente para la terapia de infecciones por virus.
Levin, S., Measroch, V., Pech, W. & Malherbe Hand-foot-and-mouth disease
SU198345A1 (ru) Лекарственный препарат
CN103550194A (zh) 一种外用兽药

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 271447

Country of ref document: ES